{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:20:32Z","timestamp":1790835632822,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"am","delay-in-days":602,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.lpm.2021.104087","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T13:27:16Z","timestamp":1635427636000},"page":"104087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pathophysiology of systemic sclerosis"],"prefix":"10.1016","volume":"50","author":[{"given":"Benjamin","family":"Thoreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2021.104087_bib0001","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.lpm.2014.08.001","article-title":"Pathophysiology of systemic sclerosis: state of the art in 2014","volume":"43","author":"Dumoitier","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0003","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajim.1098","article-title":"Meta-analysis of systemic sclerosis and exposure to solvents","volume":"40","author":"Aryal","year":"2001","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0004","first-page":"97","article-title":"Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies","volume":"34","author":"Kettaneh","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00420-009-0505-7","article-title":"Occupational silica exposure as a risk factor for scleroderma: a meta-analysis","volume":"83","author":"McCormic","year":"2010","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.lpm.2021.104087_bib0006","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/RHU.0000000000000354","article-title":"The influence of different solvents on systemic sclerosis: an updated meta-analysis of 14 case-control studies","volume":"22","author":"Zhao","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0007","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semarthrit.2015.06.004","article-title":"Clinical peculiarities of patients with scleroderma exposed to silica: a systematic review of the literature","volume":"45","author":"Freire","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0008","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2010.02.001","article-title":"Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis","volume":"35","author":"Arora-Singh","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2021.104087_bib0010","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0011","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13075-016-1127-6","article-title":"Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families","volume":"18","author":"Kuo","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2021.104087_bib0012","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/art.21355","article-title":"Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles","volume":"52","author":"Zhou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.humimm.2016.10.017","article-title":"Genomic and genetic studies of systemic sclerosis: a systematic review","volume":"78","author":"Chairta","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.lpm.2021.104087_bib0014","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2016-210645","article-title":"Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis","volume":"76","author":"Terao","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BOR.0000000000000735","article-title":"Systemic sclerosis pathogenesis: contribution of recent advances in genetics","volume":"32","author":"Orvain","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0016","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.39828","article-title":"Histone deacetylase 5 Is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors","volume":"68","author":"Tsou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0017","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.lpm.2021.104087_bib0018","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","article-title":"Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies","volume":"74","author":"Altorok","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0019","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jid.2017.12.003","article-title":"Genome-wide DNA methylation analysis in systemic sclerosis reveals hypomethylation of IFN-associated genes in CD4+ and CD8+ T cells","volume":"138","author":"Ding","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0020","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/ijmm.2012.1150","article-title":"Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1","volume":"30","author":"Bujor","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03009740902758875","article-title":"Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis","volume":"38","author":"Lei","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0022","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/exd.12767","article-title":"Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts","volume":"24","author":"Hattori","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0023","article-title":"Meta-analysis of differentially expressed microRNAs in systemic sclerosis","author":"Zhang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0024","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/art.40163","article-title":"Association of microRNA-618 expression with altered frequency and activation of plasmacytoid dendritic cells in patients with systemic sclerosis","volume":"69","author":"Rossato","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopha.2016.12.080","article-title":"MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1","volume":"87","author":"Zhou","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.lpm.2021.104087_bib0026","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2021.104087_bib0027","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","article-title":"Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis","volume":"89","author":"Chouri","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2021.104087_bib0028","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/14397595.2014.1001311","article-title":"MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor \u03b3","volume":"25","author":"Luo","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0029","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.autrev.2018.06.013","article-title":"Recent advances in mouse models for systemic sclerosis","volume":"17","author":"Yue","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2021.104087_bib0030","first-page":"617","article-title":"Increased dermal elastic fibers in the tight skin mouse","volume":"22","author":"Chatterjee","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0031","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.1780381212","article-title":"The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration","volume":"38","author":"Christner","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0032","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2133.1983.tb01080.x","article-title":"Bleomycin-induced cutaneous toxicity in the rat: analysis of histopathology and ultrastructure compared with progressive systemic sclerosis (scleroderma)","volume":"108","author":"Mountz","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-010-0142-x","article-title":"Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trials","volume":"13","author":"Iwamoto","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2021.104087_bib0034","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","article-title":"The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis","volume":"59","author":"Asano","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.lpm.2021.104087_bib0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/MCB.01278-08","article-title":"Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin","volume":"29","author":"Asano","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.lpm.2021.104087_bib0036","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2021.104087_bib0037","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1111\/jcmm.13630","article-title":"Oxidative stress in the pathogenesis of systemic scleroderma: an overview","volume":"22","author":"Vona","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0038","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","article-title":"Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway","volume":"44","author":"Sambo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/389582","article-title":"Oxidative damage and antioxidative therapy in systemic sclerosis","volume":"2014","author":"Grygiel-G\u00f3rniak","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.lpm.2021.104087_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/exd.13180","article-title":"Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis","volume":"26","author":"Dosoki","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093161","article-title":"Sildenafil reduces expression and release of IL-6 and IL-8 Induced by reactive oxygen species in systemic sclerosis fibroblasts","volume":"21","author":"Di Luigi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.lpm.2021.104087_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101122","article-title":"Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis","volume":"25","author":"Doridot","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.lpm.2021.104087_bib0043","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0044","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2021.104087_bib0045","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","article-title":"Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?","volume":"3","author":"Fleming","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2021.104087_bib0046","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00002281-200211000-00010","article-title":"Targeting mediators of vascular injury in scleroderma","volume":"14","author":"Schachna","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0047","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.1780340807","article-title":"Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action","volume":"34","author":"Kahaleh","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0048","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-291X(92)92370-D","article-title":"High reactivity of aortic fibroblasts to vasoactive agents: endothelins, bradykinin and nucleotides","volume":"188","author":"Marsault","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lpm.2021.104087_bib0049","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/art.39125","article-title":"Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor \u03b1 autoantibodies in systemic sclerosis","volume":"67","author":"Moroncini","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.lpm.2021.104087_bib0050","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1136\/annrheumdis-2013-203535","article-title":"Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis","volume":"73","author":"Maurer","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0051","doi-asserted-by":"crossref","first-page":"e68117","DOI":"10.1371\/journal.pone.0068117","article-title":"Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis","volume":"8","author":"Giusti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2021.104087_bib0052","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.37705","article-title":"Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)\/transforming growth factor \u03b2-dependent mesenchymal-to-mesenchymal transition","volume":"65","author":"Serrat\u00ec","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0053","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-2249.1998.00721.x","article-title":"Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers","volume":"114","author":"Denton","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lpm.2021.104087_bib0054","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-017-0630-3","article-title":"Innate immunity in systemic sclerosis","volume":"19","author":"Dowson","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2021.104087_bib0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/imm.12260","article-title":"Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-\u03baB","volume":"143","author":"O'Reilly","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.lpm.2021.104087_bib0056","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0057","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0058","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0059","first-page":"5","article-title":"Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients","volume":"17","author":"Mart\u00ednez-God\u00ednez","year":"2015","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.lpm.2021.104087_bib0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/ard.2010.131243","article-title":"NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis","volume":"70","author":"Dieud\u00e9","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0061","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.30568","article-title":"The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis","volume":"63","author":"Artlett","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0062","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10067-017-3597-6","article-title":"CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis","volume":"36","author":"Lescoat","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0063","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/1521-4141(2001010)31:10<2936::AID-IMMU2936>3.0.CO;2-0","article-title":"High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts","volume":"31","author":"Yamamoto","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.lpm.2021.104087_bib0064","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype","volume":"90","author":"Mathai","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.lpm.2021.104087_bib0065","doi-asserted-by":"crossref","first-page":"e33508","DOI":"10.1371\/journal.pone.0033508","article-title":"Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis","volume":"7","author":"Binai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2021.104087_bib0066","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-015-0554-8","article-title":"Macrophage involvement in systemic sclerosis: do we need more evidence?","volume":"18","author":"Stifano","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2021.104087_bib0067","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2133.1998.02114.x","article-title":"Dermal mast cells in scleroderma: their skin density, tryptase\/chymase phenotypes and degranulation","volume":"138","author":"Akimoto","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0068","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1497","article-title":"Mast cells\u2019 contribution to the fibrosing alveolitis of the scleroderma lung","volume":"147","author":"Chanez","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0069","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/rheumatology\/keu246","article-title":"Involvement of CD161+ V\u03b41+ \u03b3\u03b4 T cells in systemic sclerosis: association with interstitial pneumonia","volume":"53","author":"Segawa","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2021.104087_bib0070","first-page":"283","article-title":"Reduced circulating natural killer T cells and gamma\/delta T cells in patients with systemic sclerosis","volume":"32","author":"Riccieri","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0071","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/03009740802572467","article-title":"Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion","volume":"38","author":"van Lieshout","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0072","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0073","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98380","article-title":"pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis","volume":"3","author":"Kafaja","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.lpm.2021.104087_bib0074","first-page":"1751","article-title":"Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis","volume":"151","author":"Mavalia","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2021.104087_bib0075","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","article-title":"Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis","volume":"56","author":"Parel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0076","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/art.37706","article-title":"Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis","volume":"65","author":"Fuschiotti","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0077","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3565(24)35380-7","article-title":"Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts","volume":"292","author":"Oriente","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lpm.2021.104087_bib0078","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","article-title":"Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity","volume":"261","author":"Slobodin","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.lpm.2021.104087_bib0079","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lpm.2021.104087_bib0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.imlet.2018.01.002","article-title":"Pathogenic roles of B lymphocytes in systemic sclerosis","volume":"195","author":"Yoshizaki","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.lpm.2021.104087_bib0081","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/art.40016","article-title":"Scleroderma peripheral B lymphocytes secrete interleukin-6 and transforming growth factor \u03b2 and activate fibroblasts","volume":"69","author":"Dumoitier","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.lpm.2021.104087_bib0082","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.1780210404","article-title":"Collagen in the cellular and fibrotic stages of scleroderma","volume":"21","author":"Fleischmajer","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0083","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08830189509056712","article-title":"Regulation of connective tissue synthesis in systemic sclerosis","volume":"12","author":"Varga","year":"1995","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.lpm.2021.104087_bib0084","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/annrheumdis-2012-203194","article-title":"The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis","volume":"73","author":"Dees","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0085","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/art.34424","article-title":"Wnt\/\u03b2-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells","volume":"64","author":"Wei","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0086","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nchembio.453","article-title":"Small-molecule inhibition of Wnt signaling through activation of casein kinase 1\u03b1","volume":"6","author":"Thorne","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.lpm.2021.104087_bib0087","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1523-1747.ep12276895","article-title":"Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma","volume":"92","author":"Gay","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0088","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.1780331011","article-title":"Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis","volume":"33","author":"Klareskog","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0089","first-page":"1876","article-title":"Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma","volume":"22","author":"Ludwicka","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0090","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1074\/jbc.M010149200","article-title":"CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling","volume":"276","author":"Holmes","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2021.104087_bib0091","doi-asserted-by":"crossref","first-page":"41728","DOI":"10.1074\/jbc.M305019200","article-title":"Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1","volume":"278","author":"Holmes","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2021.104087_bib0092","first-page":"149","article-title":"Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"27","author":"Sato","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0093","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor \u03b2\u2013at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0094","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.4049\/jimmunol.175.11.7708","article-title":"Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts","volume":"175","author":"Asano","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2021.104087_bib0095","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1002\/art.22063","article-title":"Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: a model of scleroderma","volume":"54","author":"Pannu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0096","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1529-0131(200102)44:2<474::AID-ANR67>3.0.CO;2-#","article-title":"Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors","volume":"44","author":"Ihn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0097","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/scrt512","article-title":"Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner","volume":"5","author":"Birbrair","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lpm.2021.104087_bib0098","doi-asserted-by":"crossref","first-page":"R1113","DOI":"10.1186\/ar1790","article-title":"Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis","volume":"7","author":"Rajkumar","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2021.104087_bib0099","first-page":"747","article-title":"Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display","volume":"34","author":"Meyringer","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0100","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/1529-0131(200010)43:10<2219::AID-ANR9>3.0.CO;2-N","article-title":"CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts","volume":"43","author":"Saitta","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0101","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0102","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/1529-0131(200107)44:7<1667::AID-ART291>3.0.CO;2-Y","article-title":"Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts","volume":"44","author":"Santiago","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3899\/jrheum.160736","article-title":"Proteomic investigation of dermal fibroblasts isolated from affected and unaffected skin samples from patients with limited cutaneous systemic sclerosis: 2 distinct entities?","volume":"44","author":"Corallo","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/excr.2000.4972","article-title":"Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis","volume":"259","author":"Shi-wen","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.lpm.2021.104087_bib0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1523-1747.1998.00073.x","article-title":"Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype","volume":"110","author":"Kawakami","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0106","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/1529-0131(200103)44:3<731::AID-ANR124>3.0.CO;2-U","article-title":"Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma","volume":"44","author":"Kubo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0107","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1002\/art.22063","article-title":"Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: a model of scleroderma","volume":"54","author":"Pannu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0108","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/art.23698","article-title":"Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate","volume":"58","author":"Pannu","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0109","doi-asserted-by":"crossref","first-page":"41728","DOI":"10.1074\/jbc.M305019200","article-title":"Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1","volume":"278","author":"Holmes","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2021.104087_bib0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11926-013-0382-7","article-title":"Animal models of scleroderma: current state and recent development","volume":"15","author":"Asano","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2021.104087_bib0111","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-019-2052-2","article-title":"Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL\/6 mice that reproduces fibrosis, vasculopathy and autoimmunity","volume":"21","author":"Teodoro","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2021.104087_bib0112","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1084\/jem.153.6.1640","article-title":"Characterization of a spontaneous disease of white leghorn chickens resembling progressive systemic sclerosis (scleroderma)","volume":"153","author":"Gershwin","year":"1981","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0113","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.22328","article-title":"Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma","volume":"56","author":"Sonnylal","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104087_bib0114","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/BOR.0b013e32833130c1","article-title":"Animal models of scleroderma: lessons from transgenic and knockout mice","volume":"21","author":"Derrett-Smith","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0115","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2013-203706","article-title":"Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?","volume":"73","author":"Manetti","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2021.104087_bib0116","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lpm.2021.104087_bib0117","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2021.104087_bib0118","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2021.104087_bib0119","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/MCB.00586-15","article-title":"SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3\u03b2","volume":"36","author":"Sundaresan","year":"2015","journal-title":"Mol Cell Biol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:07:20Z","timestamp":1760105240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0755498221000269"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104087","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104087"}}